Skip to content

Comparison of efficacy of intralesional Injection Vitamin D3 with intralesional MMR vaccine in the management of cutaneous warts

Comparison of efficacy of intralesional Vitamin D3 with intralesional MMR vaccine in the management of cutaneous warts : a randomized controlled trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/053231
Enrollment
120
Registered
2023-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B079- Viral wart, unspecified

Interventions

Intervention1: Vitamin D3 injection: Injection Vitamin D3 0.2ml every 2 weeks for total of 4 doses or till resolution whichever is earlier. Control Intervention1: MMR Vaccine: Measles Mumps Rubella va

Sponsors

INHS Asvini dermatology dept
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All diagnosed immunocompetent cases (clinically and dermoscopically) of cutaneous warts (aged 5-70 yrs) attending Dermatology OPD in a tertiary care hospital in Mumbai.

Exclusion criteria

Exclusion criteria: Patients with keloidal tendencies. (2) Patients with prior allergic response to MMR or vitamin D3. (3)Patients with autoimmune conditions. (4) Patients with infected warts (5) Patients with genital warts. (6) Pregnant /lactating females. (7) Known case of HIV/HBsAg/HCV (8)Immunosuppressed patients. (9) Consent Denial, uncooperative patients.

Design outcomes

Primary

MeasureTime frame
Percentage of resolution of injected warts.Timepoint: Resolution of warts at weeks 2, 4, 6,24

Secondary

MeasureTime frame
To compare effect of intralesional Vitamin D3 vs MMR vaccine on the resolution of distant warts, other than injected wartsTimepoint: weeks 2,4,6,24

Countries

India

Contacts

Public ContactDr Reetu Aggrawal

INHS Asvini

gopal.270985@gmail.com07017520062

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026